A prospective multi-centre Phase III validation study of AZGP1 as a biomarker in localized prostate cancer

Zhang, A. (Speaker)

Activity: Talk or presentationOral presentation

Period13 Feb 2017 - 15 Feb 2017
Held atLorne Cancer Conference
Event typeConference
Location, Australia, Victoria
Degree of RecognitionLocal